Safety and Efficacy of Bimatoprost Timolol Ophthalmic Solution in Patients With Open Angle Glaucoma or Ocular Hypertension

Study Identifier
192024-052
CT.gov Identifier
NCT01068964
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Glaucoma - Open Angle
  • Ocular Hypertension
    • Study Drug
  • 0.03% Bimatoprost/0.5% Timolol Ophthalmic Solution
  • 0.03% Bimatoprost Ophthalmic Solution and 0.5% Timolol Ophthalmic Solution
    • Phase
    N/A
    Sex
    Female & Male
    Age
    18 - 70 Years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Diagnosis of open-angle glaucoma or ocular hypertension in one or both eyes * Eye pressure lowering topical medications are not working * Visual acuity is at least 0.2 in each eye
    Exclusion Criteria:
    * Uncontrolled systemic disease * Any other active eye disease other than glaucoma or ocular hypertension * Significant visual field loss or evidence of progressive visual field loss within the last year * Anticipated wearing of contact lenses during the study * Required chronic use of other ocular medications during the study * Eye surgery or laser treatment within 12 weeks prior to study enrollment

    Protocol Summary

    This study will evaluate the safety and efficacy of once daily administered 0.03% Bimatoprost/0.5% Timolol Ophthalmic Solution compared with once daily administered 0.03% Bimatoprost Ophthalmic Solution and once daily administered 0.5% Timolol Ophthalmic Solution concurrently in patients with open-angle glaucoma or ocular hypertension

    Study Locations

    Location
    Status
    Location
    Beijing, China
    Status
    Not applicable